Designing Prodrugs Based on Special Residues of Human Serum Albumin

Author(s): Yi Gou, Feng Yang, Hong Liang

Journal Name: Current Topics in Medicinal Chemistry

Volume 16 , Issue 9 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Human serum albumin (HSA) is the most abundant protein in the plasma. HSA plays a central role in drug pharmacokinetics because most drugs bound to HSA are delivered to their target organ/tissues. The prodrug strategies have shown great promise for improving the activity and selectivity of drugs. Designing prodrugs based on special HSA residues, such as Cys34 and Lys residues, has been extensively studied. Therefore, this review provides an overview of the development of nonsteroidal anti-inflammatory and anticancer prodrugs based on these special residues. In conclusion, this review may guide the rational design and development of new prodrugs for future clinical applications.

Keywords: Human serum albumin, Prodrug, Drug design, Protein structure.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 25 November, 2015
Page: [996 - 1008]
Pages: 13
DOI: 10.2174/1568026615666150825142908
Price: $65

Article Metrics

PDF: 57
PRC: 1